Suppr超能文献

环状肉芽肿与 2 型糖尿病、血脂异常、自身免疫性疾病和血液系统恶性肿瘤的相关性。

Association of Granuloma Annulare With Type 2 Diabetes, Hyperlipidemia, Autoimmune Disorders, and Hematologic Malignant Neoplasms.

机构信息

Department of Dermatology, University of Pennsylvania Perelman School of Medicine, Philadelphia.

Editorial Board, JAMA Dermatology.

出版信息

JAMA Dermatol. 2021 Jul 1;157(7):817-823. doi: 10.1001/jamadermatol.2021.1805.

Abstract

IMPORTANCE

Although granuloma annulare (GA) has been associated with several other conditions, these studies have been limited by single-center designs and small sample sizes.

OBJECTIVE

To evaluate whether there is an association between GA and type 2 diabetes, hyperlipidemia, autoimmune conditions, and hematologic malignant neoplasms, using a large population-based cohort study.

DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study conducted between January 1, 2016, and June 30, 2019, used deidentified data from the US Optum Clinformatics Data Mart Database. A total of 5137 patients with GA were matched by age and sex with up to 10 randomly selected controls (n = 51 169) with a diagnosis of a nevus or seborrheic keratosis.

MAIN OUTCOMES AND MEASURES

Logistic regression was used to evaluate for potential associations between GA and diabetes, hyperlipidemia, autoimmune conditions, and hematologic malignant neoplasms. All analyses were adjusted for race/ethnicity, income, and educational level.

RESULTS

This study included 5137 individuals with GA (3760 women [73.2%]; mean [SD] age, 57.7 [19.0] years) and 51 169 controls (37 456 women [73.2%]; mean [SD] age, 57.7 [19.0] years). Those with GA were more likely than controls to have baseline diabetes (1086 [21.1%] vs 6780 [13.3%]; adjusted odds ratio [aOR], 1.67; 95% CI, 1.55-1.80), hyperlipidemia (1669 [32.5%] vs 14 553 [28.4%]; aOR, 1.15; 95% CI, 1.08-1.23), hypothyroidism (727 [14.2%] vs 5780 [11.3%]; aOR, 1.24; 95% CI, 1.15-1.36), and rheumatoid arthritis (62 [1.2%] vs 441 [0.9%]; aOR, 1.34; 95% CI, 1.02-1.75). Those with GA were more likely to have incident diabetes (144 [2.8%] vs 1061 [2.1%]; aOR, 1.31; 95% CI, 1.10-1.57), hypothyroidism (41 [0.8%] vs 252 [0.5%]; aOR, 1.59; 95% CI, 1.14-2.22), systemic lupus erythematosus (21 [0.4%] vs 65 [0.1%]; aOR, 3.06; 95% CI, 1.86-5.01), and rheumatoid arthritis (26 [0.5%] vs 122 [0.2%]; aOR, 2.05; 95% CI, 1.34-3.13). There was no association between GA and an increased risk of hematologic malignant neoplasms.

CONCLUSIONS AND RELEVANCE

This population-based cohort study identified associations between GA and baseline diabetes and hyperlipidemia as well as between GA and both baseline and incident autoimmune conditions. These findings suggest that diabetes and hyperlipidemia may be risk factors for the development of GA and that autoimmunity may be an important factor in the pathogenesis of GA.

摘要

背景:虽然环状肉芽肿(GA)与其他几种疾病有关,但这些研究受到单中心设计和小样本量的限制。

目的:使用大型基于人群的队列研究评估 GA 与 2 型糖尿病、高脂血症、自身免疫性疾病和血液恶性肿瘤之间是否存在关联。

设计、地点和参与者:这项回顾性队列研究于 2016 年 1 月 1 日至 2019 年 6 月 30 日进行,使用美国 Optum Clinformatics Data Mart 数据库中的匿名数据。共有 5137 例 GA 患者按年龄和性别与多达 10 名随机选择的对照(n=51169)相匹配,对照组诊断为痣或脂溢性角化病。

主要结局和测量:使用 logistic 回归评估 GA 与糖尿病、高脂血症、自身免疫性疾病和血液恶性肿瘤之间的潜在关联。所有分析均调整了种族/民族、收入和教育水平。

结果:这项研究包括 5137 名 GA 患者(3760 名女性[73.2%];平均[SD]年龄为 57.7[19.0]岁)和 51169 名对照(37456 名女性[73.2%];平均[SD]年龄为 57.7[19.0]岁)。与对照组相比,GA 患者更有可能患有基线糖尿病(1086 例[21.1%]比 6780 例[13.3%];调整后的优势比[aOR],1.67;95%置信区间[CI],1.55-1.80)、高脂血症(1669 例[32.5%]比 14553 例[28.4%];aOR,1.15;95%CI,1.08-1.23)、甲状腺功能减退症(727 例[14.2%]比 5780 例[11.3%];aOR,1.24;95%CI,1.15-1.36)和类风湿关节炎(62 例[1.2%]比 441 例[0.9%];aOR,1.34;95%CI,1.02-1.75)。GA 患者更有可能患有新发糖尿病(144 例[2.8%]比 1061 例[2.1%];aOR,1.31;95%CI,1.10-1.57)、甲状腺功能减退症(41 例[0.8%]比 252 例[0.5%];aOR,1.59;95%CI,1.14-2.22)、系统性红斑狼疮(21 例[0.4%]比 65 例[0.1%];aOR,3.06;95%CI,1.86-5.01)和类风湿关节炎(26 例[0.5%]比 122 例[0.2%];aOR,2.05;95%CI,1.34-3.13)。GA 与血液恶性肿瘤风险增加无关。

结论:这项基于人群的队列研究确定了 GA 与基线糖尿病和高脂血症之间的关联,以及 GA 与基线和新发自身免疫性疾病之间的关联。这些发现表明,糖尿病和高脂血症可能是 GA 发展的危险因素,而自身免疫可能是 GA 发病机制中的一个重要因素。

相似文献

2
Incidence and Prevalence of Granuloma Annulare in the United States.
JAMA Dermatol. 2021 Jul 1;157(7):824-830. doi: 10.1001/jamadermatol.2021.1847.
4
Dyslipidemia in granuloma annulare: a case-control study.
Arch Dermatol. 2012 Oct;148(10):1131-6. doi: 10.1001/archdermatol.2012.1381.
5
Lack of an association between granuloma annulare and type 2 diabetes mellitus.
Br J Dermatol. 2002 Jan;146(1):122-4. doi: 10.1046/j.0007-0963.2001.04527.x.
6
Granuloma Annulare.
Dermatol Clin. 2015 Jul;33(3):315-29. doi: 10.1016/j.det.2015.03.001. Epub 2015 May 13.
7
Subcutaneous Granuloma Annulare.
Acta Dermatovenerol Croat. 2017 Dec;25(4):292-294.

引用本文的文献

2
A Retrospective Analysis of Dermatologic Manifestations of Diabetes on TikTok.
Clin Diabetes. 2025 Jan 22;43(3):361-365. doi: 10.2337/cd24-0089. eCollection 2025 Summer.
3
Dupilumab-Induced Granuloma Annulare: A Challenging Adverse Effect of Atopic Dermatitis Treatment.
Indian J Dermatol. 2025 May-Jun;70(3):158-160. doi: 10.4103/ijd.ijd_32_24. Epub 2025 May 8.
4
[Clinical variables and management of disseminated granuloma annulare - monocentric retrospective analysis of 33 cases between 2021 and 2023].
Dermatologie (Heidelb). 2025 Jan;76(1):27-33. doi: 10.1007/s00105-024-05436-2. Epub 2024 Dec 18.
5
Granuloma annulare and possible relation to purified protein derivative administration: a case report.
J Med Case Rep. 2024 Jun 20;18(1):299. doi: 10.1186/s13256-024-04598-w.
6
Characterizing Granuloma Annulare in 73 Pediatric Patients.
Dermatol Res Pract. 2023 Dec 9;2023:9267263. doi: 10.1155/2023/9267263. eCollection 2023.
7
Papular Umbilicated Granuloma Annulare in a Patient With Systemic Lupus Erythematosus.
Cureus. 2023 Oct 24;15(10):e47600. doi: 10.7759/cureus.47600. eCollection 2023 Oct.
8
Papular Granuloma Annulare Mimicking Viral Warts.
Dermatol Pract Concept. 2023 Oct 1;13(4):e2023207. doi: 10.5826/dpc.1304a207.
9
Multiple Red-brown Papules and Plaques on the Trunk and Extremities: A Quiz.
Acta Derm Venereol. 2023 Sep 18;103:adv12419. doi: 10.2340/actadv.v103.12419.

本文引用的文献

1
Use of primary care services among patients with chronic skin disease seen by dermatologists.
JAAD Int. 2020 Dec 1;2:31-36. doi: 10.1016/j.jdin.2020.10.010. eCollection 2021 Mar.
2
Incidence and Prevalence of Granuloma Annulare in the United States.
JAMA Dermatol. 2021 Jul 1;157(7):824-830. doi: 10.1001/jamadermatol.2021.1847.
3
Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.
J Allergy Clin Immunol. 2021 May;147(5):1795-1809. doi: 10.1016/j.jaci.2020.10.012. Epub 2020 Dec 11.
4
Comorbidities Associated with Granuloma Annulare: A Cross-Sectional, Case-Control Study.
Medicines (Basel). 2020 Aug 28;7(9):53. doi: 10.3390/medicines7090053.
5
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways.
J Am Acad Dermatol. 2020 Jul;83(1):63-70. doi: 10.1016/j.jaad.2019.12.028. Epub 2019 Dec 20.
6
The Role of Inflammation in Diabetes: Current Concepts and Future Perspectives.
Eur Cardiol. 2019 Apr;14(1):50-59. doi: 10.15420/ecr.2018.33.1.
8
Lack of an association between generalized granuloma annulare and malignancy: A case-control study.
J Am Acad Dermatol. 2019 Jun;80(6):1799-1800. doi: 10.1016/j.jaad.2019.02.056. Epub 2019 Feb 28.
9
Immune checkpoint inhibitors and the development of granulomatous reactions.
J Am Acad Dermatol. 2019 Nov;81(5):1165-1175. doi: 10.1016/j.jaad.2018.07.051. Epub 2018 Aug 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验